Fyodor Urnov

Fyodor Urnov is the Director for Technology and Translation at the Innovative Genomics Institute and a Professor of Molecular Therapeutics in the Department of Molecular and Cell Biology at UC Berkeley. He co-developed the toolbox of human genome and epigenome editing, co-named genome editing, and was on the team that advanced all of its first-in-human applications to the clinic. He also led the effort that identified the genome editing target for an approved medicine to treat sickle cell disease and beta-thalassemia. A major goal for the field of genome editing and a key focus of Fyodor's work is expanding access to CRISPR therapies for genetic disease. As part of that effort Fyodor directs the Danaher-IGI Beacon for CRISPR Cures - a first-in-class academia-industry partnership developing and advancing to the clinic scalable CRISPR-based approaches to treat diseases of the immune system. Fyodor also leads cross-functional teams in developing and advancing to the clinic CRISPR-based approaches to treat neurodegenerative, neuroinflammatory, and infectious diseases.

Please note that speakers provide their own biographies and headshots. Biographies represent the role of the person at the time of their engagement and are not independently verified by the Milken Institute.